2022
DOI: 10.14202/vetworld.2022.1163-1170
|View full text |Cite
|
Sign up to set email alerts
|

A novel cross-species differential tumor classification method based on exosome-derived microRNA biomarkers established by human-dog lymphoid and mammary tumor cell lines' transcription profiles

Abstract: Background and Aim: Exosome-derived microRNA (miRNA) has been widely studied as a non-invasive candidate biomarker for tumor diagnosis in humans and dogs. Its application, however, was primarily focused on intraspecies usage for individual tumor type diagnosis. This study aimed to gain insight into its application as a cross-species differential tumor diagnostic tool; we demonstrated the process of identifying and using exosome-derived miRNA as biomarkers for the classification of lymphoid and mammary tumor ce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 36 publications
0
1
0
Order By: Relevance
“…Similar analysis was performed on serum exosomes isolated from dogs affected by Leishmaniosis and associated alterations demonstrating that the decrease in exosomal miR-122-5p, associated with serum levels of high-density lipoproteins, and increased serum levels of low-density lipoproteins could be a predictive indicator of disease [131]. Notably, a recent paper demonstrated for the first time that miRNAs can be used as tumor diagnostic tool for cross-species differentiation, classifying human and canine lymphoid tumor cell lines [132]. Moreover, this diagnostic approach has been shown to be helpful in excluding pulmonary metastasis.…”
Section: Exosomes As Emerging Diagnostic Biomarkersmentioning
confidence: 99%
“…Similar analysis was performed on serum exosomes isolated from dogs affected by Leishmaniosis and associated alterations demonstrating that the decrease in exosomal miR-122-5p, associated with serum levels of high-density lipoproteins, and increased serum levels of low-density lipoproteins could be a predictive indicator of disease [131]. Notably, a recent paper demonstrated for the first time that miRNAs can be used as tumor diagnostic tool for cross-species differentiation, classifying human and canine lymphoid tumor cell lines [132]. Moreover, this diagnostic approach has been shown to be helpful in excluding pulmonary metastasis.…”
Section: Exosomes As Emerging Diagnostic Biomarkersmentioning
confidence: 99%